Blogs
When GLP-1 Spend Spikes: PBM Strategies for Step Therapy, Exceptions & Equity
Unlike many specialty therapies, GLP-1 utilization is coming through consumers who are actively seeking treatment informed by direct-to-consumer marketing, social media, and cultural momentum around weight loss and metabolic health. Learn how defensible, non-discriminatory utilization management anchored in thoughtful PBM strategies can help control GLP-1 and specialty drug spend.
Read Now